Treatment of multidrug-resistant tuberculosis (TB) has comparable efficacy and survival rates in patients infected with HIV and not uninfected with HIV when patients with HIV are given antiretroviral therapy, according to the results of recent research published in Clinical Infectious Diseases.

According to a recent study published in Clinical Infectious Diseases, the presence of diabetes mellitus (DM) increases risk for mortality during tuberculosis treatment, but metformin use may counteract that risk.